BioCryst Pharmaceuticals Inc said on Monday a dose of its experimental antiviral drug improved survival rates in mice infected with the Zika virus in a preclinical study.Source: Reuters
Filed Under: Drug Discovery
BioCryst’s Zika Drug Shows Promise in Mice
BioCryst Pharmaceuticals Inc said on Monday a dose of its experimental antiviral drug improved survival rates in mice infected with the Zika virus in a preclinical study.Filed Under: Drug Discovery
